SOTIO

SOTIO

Best Immunotherapy Biotech Company - CEE

SOTIO is an international biotechnology company building a diverse portfolio through its own research & development, collaborations, in-licensing, investments, mergers and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells. SOTIO is conducting multiple Phase I to Phase III clinical trials verifying the safety and efficacy of its DCVAC products. SOTIO is also collaborating with with several other biotechnology companies and developing various new methods of treatment of cancer.

www.sotio.com